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Clinical PerspectiveWhat Is New?The present study indicated for the first time the longitudinal changes in home blood pressure (BP), home pulse rate, and their day‐to‐day variability with a prospective cohort design.Home systolic BP linearly increased, but there was an inverse‐U‐shaped age‐related trend in home diastolic BP.Day‐to‐day systolic BP variability linearly increased with age but there was a U‐shaped association between day‐to‐day diastolic BP variability and age, without any significant sex differences, and the home PR and day‐to‐day PR variability decreased with age.What Are the Clinical Implications?Present descriptive data are needed to predict the future home BP, home PR, and their day‐to‐day variability.The present findings may provide information on the mechanism of day‐to‐day BP and PR variability.

Introduction {#jah34310-sec-0008}
============

High blood pressure (BP) is still strongly related to health deterioration worldwide,[1](#jah34310-bib-0001){ref-type="ref"} but is a preventable and modifiable risk factor. Information on the change in BP during the life course is essential from both clinical and public health standpoints because it is associated with the prediction and prevention of BP elevation with age. Previous prospective studies based on the general population indicate the age‐related trends in office BPs.[2](#jah34310-bib-0002){ref-type="ref"}, [3](#jah34310-bib-0003){ref-type="ref"}, [4](#jah34310-bib-0004){ref-type="ref"}, [5](#jah34310-bib-0005){ref-type="ref"}, [6](#jah34310-bib-0006){ref-type="ref"} However, recent guidelines recommend the measurement of out‐of‐office BP[7](#jah34310-bib-0007){ref-type="ref"}, [8](#jah34310-bib-0008){ref-type="ref"}, [9](#jah34310-bib-0009){ref-type="ref"} since it is a more reliable predictor of prognosis and strongly related to target organ damages than office BP.[10](#jah34310-bib-0010){ref-type="ref"}, [11](#jah34310-bib-0011){ref-type="ref"}, [12](#jah34310-bib-0012){ref-type="ref"}

Home BP is the self‐measured BP not in the office or clinic but in a home setting under a stable condition.[13](#jah34310-bib-0013){ref-type="ref"} Home BP is a more accurate prognosticator than office BP because of the greater number of readings, elimination of the white‐coat effect, and avoidance of measurement error through the use of automated BP monitors.[13](#jah34310-bib-0013){ref-type="ref"} Furthermore, the multiple measurements of home BP allow the observation of home pulse rate (PR) as well as day‐to‐day BP and PR variability, which are associated with an elevated risk for cardiovascular disease.[14](#jah34310-bib-0014){ref-type="ref"}, [15](#jah34310-bib-0015){ref-type="ref"}, [16](#jah34310-bib-0016){ref-type="ref"}, [17](#jah34310-bib-0017){ref-type="ref"}, [18](#jah34310-bib-0018){ref-type="ref"} Furthermore, day‐to‐day BP variability is a predictor for cognitive decline and dementia.[19](#jah34310-bib-0019){ref-type="ref"}, [20](#jah34310-bib-0020){ref-type="ref"}

Some previous cross‐sectional studies including ours show the home BP, home PR, and their day‐to‐day variability across age groups.[21](#jah34310-bib-0021){ref-type="ref"}, [22](#jah34310-bib-0022){ref-type="ref"}, [23](#jah34310-bib-0023){ref-type="ref"} However, since an elevated BP at a younger age results in fatal cardiovascular events in later life, the cross‐sectional study design contributes to an underestimation of BP in elderly individuals. Moreover, in previous studies, the day‐to‐day variability in BP or PR was evaluated as the interindividual SD.[22](#jah34310-bib-0022){ref-type="ref"}, [23](#jah34310-bib-0023){ref-type="ref"} The SD is known to be strongly affected by the corresponding mean level. The information on sex difference between these age‐related trends is also limited.

We assessed age‐related trends in home BP, home PR, and day‐to‐day BP or PR variability according to sex using prospective data. The prospective cohort design can exclude survival bias[24](#jah34310-bib-0024){ref-type="ref"} because interindividual changes in BPs with age can be observed. The day‐to‐day variability was evaluated as the coefficient of variation (CV), which is the SD divided by the mean level.

Methods {#jah34310-sec-0009}
=======

Because of the sensitive nature of the data from the Japanese cohort, the data and study materials will not be made available to other researchers for purposes of the reproduction of results or replication of the procedure. All analytical methods will be described in this section.

Study Design {#jah34310-sec-0010}
------------

This report was part of the Ohasama study, which is a prospective cohort study that was started in 1986. Details of the study including socioeconomic and demographic characteristics of this region have been described previously.[25](#jah34310-bib-0025){ref-type="ref"}, [26](#jah34310-bib-0026){ref-type="ref"} The study complied with the Declaration of Helsinki, and the study protocol was approved by the Institutional Review Boards of Teikyo University, Tohoku Medical and Pharmaceutical University, and Tohoku University.

We first performed the largest examination for home BP measurements between 1988 and 1995. After 1997, we conducted follow‐up examinations every 4 years. For the current analyses, the data collected between 1988 and 1995 were used as the baseline, and those collected between 1997 and 2017 were used as the follow‐up data.

Participants {#jah34310-sec-0011}
------------

We contacted all 4969 residents aged ≥35 years in Ohasama between 1988 and 1995. Residents were ineligible if they were not at home during working hours of study investigators or nurses (n*=*1057) or if they were hospitalized (n*=*166) or incapacitated (n*=*94). Of the remaining 3652 residents, 3090 (84.6%) participated at baseline. We further excluded 1425 participants from the analysis because they did not undergo home BP or home PR measurements ≥5 days at baseline (n*=*537), did not participate in the follow‐up examinations for home BP measurements (n=829), or did not undergo home BP or home PR measurements ≥5 days at the follow‐up examination (n=59). Thus, the total number of participants analyzed was 1665. All participants provided informed consent.

BP Measurements {#jah34310-sec-0012}
---------------

Public health nurses or study investigators instructed participants how to measure their home BP using the Omron HEM 401C,[27](#jah34310-bib-0027){ref-type="ref"} 701C, 747IC‐N, or 7080IC cuff‐oscillometric device (Omron Healthcare, Kyoto, Japan).[22](#jah34310-bib-0022){ref-type="ref"}, [27](#jah34310-bib-0027){ref-type="ref"}, [28](#jah34310-bib-0028){ref-type="ref"}, [29](#jah34310-bib-0029){ref-type="ref"}, [30](#jah34310-bib-0030){ref-type="ref"} The last 3 devices are similar to HEM‐705IT, which was previously validated.[22](#jah34310-bib-0022){ref-type="ref"}, [29](#jah34310-bib-0029){ref-type="ref"}, [30](#jah34310-bib-0030){ref-type="ref"}

Participants were asked to measure their home BP for 4 weeks, after ≥2 minutes of rest in the morning within 1 hour after awakening, maintaining the arm‐cuff position at heart level during rest, and, if applicable, before taking their BP‐lowering medications.[7](#jah34310-bib-0007){ref-type="ref"}, [13](#jah34310-bib-0013){ref-type="ref"}, [31](#jah34310-bib-0031){ref-type="ref"} Although some participants measured BP twice or more per occasion, the first value from each measurement was used in order to exclude individual selection bias.[13](#jah34310-bib-0013){ref-type="ref"} We defined home BP and PR as the mean of all measurements. Day‐to‐day variability of home BP or PR was computed as within‐subject CV of measurements as well as SD.

Data Collection {#jah34310-sec-0013}
---------------

At baseline, study nurses measured anthropometric characteristics and administered questionnaires inquiring into each participant\'s medical history, medication use, and smoking and alcohol consumption. Hypercholesterolemia was defined as a serum cholesterol level ≥5.68 mmol/L (220 mg/dL) or use of lipid‐lowering drugs. Diabetes mellitus was defined as a random glucose level ≥11.1 mmol/L (≥200 mg/dL), a fasting glucose level ≥7.0 mmol/L (≥126 mg/dL), or the use of oral antidiabetic drugs or insulin.

Statistical Analysis {#jah34310-sec-0014}
--------------------

To analyze the differences in participant characteristics between groups, we compared means and proportions using a *t* test and the Fisher exact test for univariate analysis. For computing age‐adjusted *P* values, we used logistic regression analysis.

We assessed adjusted age‐related trends of BP, PR, and their day‐to‐day variability by a repeated‐measures mixed linear model with autoregressive order 1 (AR (1)) correlation structure. AR(1) is a standard method for the covariance matrix in mixed model analyses of longitudinal data.[3](#jah34310-bib-0003){ref-type="ref"} The mixed model included age, sex, an interaction term (age×sex), and the following parameters at baseline as the fixed effect: body mass index, current smoking, alcohol consumption, diabetes mellitus, hyperlipidemia, history of cardiovascular disease, and antihypertensive medication use.

The age at baseline and follow‐up duration are dependent on the participants. Least‐square means of each time point of 5‐year increase subsets from those aged 35 and \>80 years were used for age‐related trends. We interpolated missing values of body mass index (n=27) from the regression slope on age after stratification for sex. For participants with unknown alcohol consumption status (n=346), we set design variables coded 1 or 0 if the data were missing or present. We included 7 participants with unknown smoking status into nonsmokers because of the small number of missing values. We performed the stratification analysis according to the use of antihypertensive medication. Our previous studies demonstrated that day‐to‐day BP and PR variability, home BP, and home PR were associated with each other.[32](#jah34310-bib-0032){ref-type="ref"}, [33](#jah34310-bib-0033){ref-type="ref"} Therefore, in a sensitivity analysis, the age‐related trend in day‐to‐day BP variability was further adjusted for home BP, home PR, and day‐to‐day PR variability. Similarly, the age‐related trend in day‐to‐day PR variability was further adjusted for home BP, home PR, and day‐to‐day BP variability. The mixed model computed the least‐squares means as well as standard errors of BP, PR, and their day‐to‐day variability according to the category and tested the difference among all 20 sex‐age groups after Tukey‐Kramer adjustment. To assess the difference between actual measurements and estimated values, the calculated values from 1‐way analysis of covariance (ANCOVA), in which missing data are not allowed, were compared with the estimated values from the mixed data. The present longitudinal data were treated as cross‐sectional data when the 1‐way ANCOVA analysis was used. Statistical significance was set at an α‐level \<0.05 on 2‐tailed tests. Data are expressed as mean±SD, unless otherwise noted. SAS version 9.4 (SAS Institute, Cary, NC) was used in the statistical analysis.

Results {#jah34310-sec-0015}
=======

Participant Characteristics {#jah34310-sec-0016}
---------------------------

Of the 1665 participants, 1065 (64.0%) were female. At baseline, 433 (26.0%) were treated with antihypertensive medications, and the mean values were 56.2±10.6 years for age, 121.6±13.9 mm Hg for home systolic BP, 74.1±9.8 mm Hg for home diastolic BP, 67.3±7.5 beats per minute for home PR, 6.8±2.2% for CV of home systolic BP, 8.7±3.1% for CV of home diastolic BP, and 8.4±3.2% for CV of home PR. Baseline characteristics according to sex and age at baseline are presented in Table [S1](#jah34310-sup-0001){ref-type="supplementary-material"}. In both women and men, the proportion of participants receiving antihypertensive therapy, home systolic BP, and CV of home systolic BP consistently increased with an increase in the baseline age (Table [S1](#jah34310-sup-0001){ref-type="supplementary-material"}).

The present study included a higher proportion of middle‐aged to young or old individuals than observed in the population of Ohasama in 1990 (Figure [S1](#jah34310-sup-0001){ref-type="supplementary-material"}). We compared 1665 participants included in the present analysis with 888 who did not visit for follow‐up examination but for whom home BP and PR information at baseline was available. We found that the participants not visiting for follow‐up examinations were significantly older, and after adjustment for age, had a significantly higher proportion of smokers, home systolic BP, and home PR, among both women and men (Table [S2](#jah34310-sup-0001){ref-type="supplementary-material"}).

Age‐Related Trends {#jah34310-sec-0017}
------------------

The mean follow‐up period between the baseline and final visit was 15.9±6.0 years (median, 14.5 years; 25th--75th percentiles, 10.3--21.7 years). The number of follow‐up examinations without baseline visit was 1, 2, 3, 4, or 5 in 588, 447, 300, 259, and 71 participants, respectively. Numbers of observations according to age category are indicated in Table [S3](#jah34310-sup-0001){ref-type="supplementary-material"}. Therefore, we used a total of 5438 points of measurements including those at baseline and follow‐up examinations.

The age‐related trends in home BPs are shown in Figure [1](#jah34310-fig-0001){ref-type="fig"}. The home systolic BP increased with age in both women and men. The home systolic BP in men were higher than those in women aged \<70 years. Meanwhile, the sex difference in home systolic BP gradually diminished with age. The home diastolic BP in men increased to 83.2 mm Hg in those aged 55 to 59 years and decreased with age after the peak. In women, the home diastolic BP increased to 78.4 mm Hg in those aged 65 to 69 years and slightly decreased to 77.2 mm Hg in those aged 75 to 79 years (Figure [1](#jah34310-fig-0001){ref-type="fig"}).

![Age‐related trends in home BPs according to sex. The mixed model included age, sex, interaction term (age×sex), and the following parameters at baseline: body mass index, current smoking status, alcohol consumption, diabetes mellitus, hyperlipidemia, history of cardiovascular disease, and antihypertensive medication use. BP indicates blood pressure. \**P*\<0.05 vs women after adjusting with Tukey--Kramer test.](JAH3-8-e012121-g001){#jah34310-fig-0001}

The CV of home systolic BP consistently increased with age in those aged \>40 years (Figure [2](#jah34310-fig-0002){ref-type="fig"}). The CVs of home diastolic BP decreased to 7.4% for men and 7.6% for women in those aged 65 to 69 years and increased with age after the points. No significant sex differences in the CVs of home BPs were observed (*P*≥0.22 after Tukey‐Kramer adjustment) (Figure [2](#jah34310-fig-0002){ref-type="fig"}).

![Age‐related trends in CVs of home BPs according to sex. The mixed model included the same variables as those indicated in Figure [1](#jah34310-fig-0001){ref-type="fig"}. Bars indicate standard errors. There was no significant difference between women and men. BP indicates blood pressure; CV, coefficient of variation.](JAH3-8-e012121-g002){#jah34310-fig-0002}

The home PR decreased with age, and the home PR in women aged 70 to 79 years was significantly higher than that in men with the same age (*P*≤0.014 after Tukey‐Kramer adjustment) (Figure [3](#jah34310-fig-0003){ref-type="fig"}). The CV of home PR decreased with age in both women and men but tended to be higher in men than in women. The CV of home PR in men aged 50 to 59 years was significantly higher than that in women (*P*≤0.035 after Tukey‐Kramer adjustment).

![Age‐related trends in home PR and CV of home PR according to sex. The mixed model included the same variables as those indicated in Figure [1](#jah34310-fig-0001){ref-type="fig"}. Bars indicate standard errors. CV indicates coefficient of variation; PR, pulse rate. \**P*\<0.05 vs women after adjusting with Tukey--Kramer test.](JAH3-8-e012121-g003){#jah34310-fig-0003}

The results with no adjustments for confounding factors are shown in Figure [S2](#jah34310-sup-0001){ref-type="supplementary-material"}. Similar results were observed in relation to the age‐related trends of home PR and CVs of BP and PR, while the differences in systolic BP and diastolic BP between men and women were wider than those adjusted for confounding factors.

Sensitivity Analysis {#jah34310-sec-0018}
--------------------

Similar results were observed even after excluding the participants who visited \<3 times for follow‐up (Figure [S3](#jah34310-sup-0001){ref-type="supplementary-material"}) or using data based on 4263 observations of 1232 participants untreated at baseline (Figure [S4](#jah34310-sup-0001){ref-type="supplementary-material"}). In 680 untreated participants at baseline and during follow‐up (2164 observations), the systolic BP in men and diastolic BP in women after 70 years seemed to increase more clearly than those in all participants, although the age‐related trends in BP or PR indices are almost similar (Figure [S5](#jah34310-sup-0001){ref-type="supplementary-material"}). In 433 participants treated at baseline (1175 observations), the home systolic BP and CV of home systolic BP similarly increased with age, while the home diastolic BP decreased with age in those aged \>45 years (Figure [S6](#jah34310-sup-0001){ref-type="supplementary-material"}). Although age‐related trends in home PR and CVs of home diastolic BP and PR appear to be similar, the ranges of standard errors were wide (Figure [S6](#jah34310-sup-0001){ref-type="supplementary-material"}).

Further adjustments for home systolic/diastolic BP, home PR, and CV of home PR did not largely change the age‐related trends in CVs of home systolic/diastolic BP (Figure [S7](#jah34310-sup-0001){ref-type="supplementary-material"}). The age‐related trends in CVs of home PR were also similar even after further adjustments for home PR, home systolic BP, and CV of home systolic BP at the same follow‐up examinations (Figure [S7](#jah34310-sup-0001){ref-type="supplementary-material"}).

The age‐related trends in SDs of home BP and PR were similar to those in CVs (Figure [S8](#jah34310-sup-0001){ref-type="supplementary-material"}). The SD of home systolic BP in women/men linearly increased from 7.3/7.3 mm Hg in those aged 40 to 44 years to 12.5/12.1 mm Hg in those aged \>80 years. The SD of home diastolic BP in women/men decreased to 6.0/5.9 mm Hg in those aged 65 to 59 years but subsequently increased to 6.5/6.6 mm Hg in those aged \>80 years. The SD of home PR decreased with age and was higher in men than in women. These age‐related trends remained after further adjustments for home BP or PR at the same follow‐up examinations (Figure [S8](#jah34310-sup-0001){ref-type="supplementary-material"}).

We performed the stratified analysis according to the median follow‐up of 14.5 years instead of sex (Figure [S9](#jah34310-sup-0001){ref-type="supplementary-material"}). While age‐related trends in the participants with longer follow‐up period were similar to the main results in Figures [1](#jah34310-fig-0001){ref-type="fig"}, [2](#jah34310-fig-0002){ref-type="fig"} through [3](#jah34310-fig-0003){ref-type="fig"}, PR levels, day‐to‐day diastolic BP variability, and day‐to‐day PR variability in those with follow‐up of \<14.5 years were higher after ≈65 years (Figure [S9](#jah34310-sup-0001){ref-type="supplementary-material"}). Participants with a short follow‐up period had significantly older age, higher body mass index, higher proportions of diabetes mellitus, history of cardiovascular disease, used antihypertensive treatment, had higher home BP and PR levels, and elevated day‐to‐day systolic BP variability (Table [S4](#jah34310-sup-0001){ref-type="supplementary-material"}). Although the stratified analysis was similarly performed according to the baseline year of 1992 (Figure [S10](#jah34310-sup-0001){ref-type="supplementary-material"}), no significant difference was found in age‐related trends in BP or PR indices between the 1998 to 1991 and 1992 to 1995 groups.

We compared the results from ANCOVA and the mixed model. The age‐related trends in BP, PR, and the day‐to‐day variability obtained using the ANCOVA were similar to those from the mixed model (Figure [S11](#jah34310-sup-0001){ref-type="supplementary-material"}).

Discussion {#jah34310-sec-0019}
==========

The present study indicated for the first time the longitudinal changes in home BP, home PR, and their day‐to‐day variability with a prospective cohort design. Home systolic BP linearly increased with age. There was an inverse‐U‐shaped age‐related trend in home diastolic BP. Day‐to‐day systolic BP variability increased linearly with age, but a U‐shaped association between day‐to‐day diastolic BP variability and age was observed. The home PR and day‐to‐day PR variability decreased with age.

The IDHOCO (International Database of Home Blood Pressure in Relation to Cardiovascular Outcome) study, which is a meta‐analysis including the Ohasama study, demonstrated almost similar age‐related trends in home systolic and diastolic BPs in untreated participants by a cross‐sectional study design.[21](#jah34310-bib-0021){ref-type="ref"} However, the sex difference and age‐related trend in day‐to‐day BP and PR variability are not shown in the IDHOCO study.[21](#jah34310-bib-0021){ref-type="ref"} As the present study indicated, women have lower home systolic and diastolic BPs \<70 years of age, but the sex differences in home BPs seemed to be diminished in elderly individuals. Although 1 previous prospective cohort study based on office BP indicated a parallel shift in the time course of systolic BP by sex,[2](#jah34310-bib-0002){ref-type="ref"} other results from several studies[5](#jah34310-bib-0005){ref-type="ref"}, [34](#jah34310-bib-0034){ref-type="ref"} were consistent with our findings. The peak of home diastolic BP was at 55 to 59 years in men but 65 to 69 years in women. Diastolic BP in women without treatment at baseline and during follow‐up linearly increased without the peak (Figure [S5](#jah34310-sup-0001){ref-type="supplementary-material"}). Since a decreased diastolic BP indicates atherosclerosis or target organ damage,[35](#jah34310-bib-0035){ref-type="ref"} this result may imply that estrogen or other sex‐related differences weaken the progression of atherosclerosis.[36](#jah34310-bib-0036){ref-type="ref"}

The age‐related linear trend of day‐to‐day systolic BP variability was observed even after further adjusting the home BP. Meanwhile, the day‐to‐day diastolic BP variability decreased until 65 to 69 years of age and increased thereafter. In relation to day‐to‐day diastolic BP variability, the mechanisms of age‐related trend in those aged \<65 and ≥65 years may be different. For those aged ≥65 years, both day‐to‐day systolic and diastolic BP variability increased with age. Previous prospective studies indicated the positive association of day‐to‐day systolic and diastolic BP variability with cognitive deterioration or dementia.[19](#jah34310-bib-0019){ref-type="ref"}, [20](#jah34310-bib-0020){ref-type="ref"} These studies were based on the population with a mean age of 63 years[19](#jah34310-bib-0019){ref-type="ref"} or 71 years at baseline.[20](#jah34310-bib-0020){ref-type="ref"} We also reported that common factors associated with higher day‐to‐day systolic and diastolic BP variability were older age, female sex, elevated home BP, low home PR, elevated home PR variability, alcohol consumption, and sedentary lifestyle.[32](#jah34310-bib-0032){ref-type="ref"} These factors including cognitive function may be involved in age‐related trends of day‐to‐day systolic and diastolic BP variability in those aged \>65 years. However, the mechanisms of age‐related trends in day‐to‐day diastolic BP variability in individuals aged \<65 years are unclear. No specific factors associated with day‐to‐day systolic or diastolic BP variability have been found. The difference in age‐related trends between day‐to‐day systolic and diastolic BP variability may occur because of changes in adrenergic response or BP augmentation, which can cause isolated systolic hypertension in young adults.[37](#jah34310-bib-0037){ref-type="ref"}

Similar to those in previous cross‐sectional reports, the PR decreased with age and women had higher PR than men.[14](#jah34310-bib-0014){ref-type="ref"}, [22](#jah34310-bib-0022){ref-type="ref"}, [38](#jah34310-bib-0038){ref-type="ref"} There is scarce information on day‐to‐day PR variability,[22](#jah34310-bib-0022){ref-type="ref"} while many studies indicated the short‐term heart rate variability such as R‐R intervals measured by 24‐hour ambulatory Holter echocardiography monitoring.[38](#jah34310-bib-0038){ref-type="ref"}, [39](#jah34310-bib-0039){ref-type="ref"}, [40](#jah34310-bib-0040){ref-type="ref"} The short‐term heart rate variability decreased with age and was higher in men than in women.[38](#jah34310-bib-0038){ref-type="ref"}, [39](#jah34310-bib-0039){ref-type="ref"}, [40](#jah34310-bib-0040){ref-type="ref"} Therefore, the age‐related trend in short‐term heart rate variability appears to be similar to that of day‐to‐day PR variability. However, our previous study demonstrated that the correlation coefficient between within‐day PR variability determined by ambulatory monitoring and day‐to‐day PR variability was only 0.08.[33](#jah34310-bib-0033){ref-type="ref"} Factors associated with within‐day PR variability differed from those associated with day‐to‐day PR variability. [33](#jah34310-bib-0033){ref-type="ref"} Moreover, day‐to‐day PR variability was positively associated[16](#jah34310-bib-0016){ref-type="ref"} but short‐term PR variability was inversely associated with cardiovascular disease.[41](#jah34310-bib-0041){ref-type="ref"} We recently reported the positive associations of day‐to‐day BP and PR variability with a high N‐terminal pro‐B‐type natriuretic peptide level.[42](#jah34310-bib-0042){ref-type="ref"} Based on these results,[16](#jah34310-bib-0016){ref-type="ref"}, [42](#jah34310-bib-0042){ref-type="ref"} an elevated day‐to‐day PR variability can be a risk factor for cardiovascular disease or target organ damage. There is a discrepancy between the associations of day‐to‐day PR variability with an elevated cardiovascular risk and age‐related trend. This is also the case in PR level,[43](#jah34310-bib-0043){ref-type="ref"} diastolic BP level, and day‐to‐day diastolic BP variability.[16](#jah34310-bib-0016){ref-type="ref"} An intraindividual age‐related trend can be distinguished from its predictive power assessed by a longitudinal analysis.

The short follow‐up period was associated with higher PR, day‐to‐day diastolic BP variability, and day‐to‐day PR variability after ≈65 years (Figure [S9](#jah34310-sup-0001){ref-type="supplementary-material"}). When compared with the participants with a long follow‐up period, those with a short follow‐up period had more risk factors of cardiovascular disease (Table [S4](#jah34310-sup-0001){ref-type="supplementary-material"}), which can lead to a worse prognosis. This implies that the age‐related trend in PR and day‐to‐day diastolic BP or PR variability might be associated with future health conditions.

The present study has several limitations. First, the present study excluded older participants with high BP or high PR and potentially included healthy individuals (Figure [S1](#jah34310-sup-0001){ref-type="supplementary-material"} and Table [S2](#jah34310-sup-0001){ref-type="supplementary-material"}). Owing to this bias, the underestimation of home BP or home PR in older age could persist, although a longitudinal analysis was performed in the present study. Furthermore, since all study participants were Japanese, the external validity of the findings could be limited. However, a linear age‐related trend in systolic BP and the inverse‐U‐shaped association between diastolic BP and age were cross‐sectionally observed in Western populations.[6](#jah34310-bib-0006){ref-type="ref"}, [21](#jah34310-bib-0021){ref-type="ref"} The age‐related trends in BP or PR indices found in the present study might be similar among Asian and Western populations. Second, the systolic BP decreased during the past decades.[44](#jah34310-bib-0044){ref-type="ref"} The BPs in younger age, which were collected in an earlier period, may be overestimated because they could be affected by the baseline levels, which were collected around the 1990s. Furthermore, management guidelines for hypertension had also changed during the follow‐up in the present study. The target office systolic/diastolic BP in patients aged ≥65 years was \<140/90 mm Hg in the Japanese Society of Hypertension (JSH) 2009 guideline.[28](#jah34310-bib-0028){ref-type="ref"} However, in the 2014 JSH guideline, the target office BP in those aged ≥75 years was changed to \<150/90 mm Hg (if tolerance is present, \<140/90 mm Hg).[7](#jah34310-bib-0007){ref-type="ref"} The thresholds based on home BP is 5 mm Hg lower than these target values. These guideline changes might also have affected the present findings. Third, we could not consider participants' occupations, daily activities, or food consumption, which might also affect day‐to‐day BP variability in the present study. These factors can cause, for instance, differences in the age‐related trend between diastolic BP level and its day‐to‐day variability. Frailty can also affect BP or PR, especially in individuals aged \>70 years. Although frailty had not been investigated in the present study, most participants could measure their home BP and participate in our investigations. The present study includes few individuals with severe frailty or who were bedridden. Finally, comparing the results from ANCOVA and the mixed model (Figure [S11](#jah34310-sup-0001){ref-type="supplementary-material"}), it appears that the estimation of missing values by the mixed model could be limited in the present study. However, it also suggests that the mixed model estimates robust values, not unrealistic ones.

Conclusions {#jah34310-sec-0020}
===========

We demonstrate the age‐related trends in home BP, home PR, and their day‐to‐day variability by a prospective study based on the home BP data obtained in multiple examinations. The home BP was higher in men than in women, but the sex difference appears to diminish in elderly individuals. The age‐related trends in day‐to‐day BP variability, especially day‐to‐day diastolic BP variability, differed from the mean values. Present descriptive data are needed to predict the future home BP and home PR. Furthermore, the present findings may provide information on the mechanism of day‐to‐day BP and PR variability.
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